YoVDO

Oral Anticoagulation in 2024: Lessons from Randomized Trials

Offered By: University of Ottawa Heart Institute via YouTube

Tags

Anticoagulation Courses Pharmacology Courses Hematology Courses Clinical Trials Courses Evidence-Based Medicine Courses Medical Research Courses Atrial Fibrillation Courses Thrombosis Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore the latest insights on oral anticoagulation in this comprehensive grand rounds presentation by Professor John Eikelboom from McMaster University. Delve into crucial lessons drawn from randomized trials as Dr. Eikelboom, a senior investigator at the Population Health Research Institute, shares his expertise on the current state and future directions of anticoagulation therapy. Gain valuable knowledge about the evolving landscape of oral anticoagulants, their efficacy, safety profiles, and potential implications for clinical practice in 2024 and beyond. This 56-minute lecture offers a unique opportunity to stay abreast of cutting-edge developments in the field of anticoagulation management, essential for healthcare professionals involved in treating patients with thromboembolic disorders.

Syllabus

Oral Anticoagulation in 2024: Lessons from the randomized trials - Grand Rounds


Taught by

University of Ottawa Heart Institute

Related Courses

Antimicrobial Stewardship: Optimization of Antibiotic Practices
Stanford University via Coursera
Teaching and Assessing Clinical Skills
University of Michigan via Coursera
Medicating for Mental Health: Judicious Use of Psychiatric Drugs
Colgate University via edX
Improving the Health of Women, Children and Adolescents: from Evidence to Action
London School of Hygiene & Tropical Medicine via FutureLearn
Health Technology Assessment: Choosing Which Treatments Get Funded
The University of Sheffield via FutureLearn